Claritev Corporation (CTEV)
NYSE: CTEV · Real-Time Price · USD
39.39
+0.61 (1.57%)
At close: Aug 28, 2026, 4:00 PM EDT
40.17
+0.78 (1.98%)
After-hours: Aug 28, 2026, 7:30 PM EDT
Claritev Revenue
Claritev had revenue of $257.48M in the quarter ending June 30, 2026, with 6.59% growth. This brings the company's revenue in the last twelve months to $994.67M, up 6.32% year-over-year. In the year 2025, Claritev had annual revenue of $965.41M with 3.74% growth.
Revenue (ttm)
$994.67M
Revenue Growth
+6.32%
P/S Ratio
0.67
Revenue / Employee
$331,556
Employees
3,000
Market Cap
667.56M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 965.41M | 34.79M | 3.74% |
| Dec 31, 2024 | 930.62M | -30.90M | -3.21% |
| Dec 31, 2023 | 961.52M | -118.19M | -10.95% |
| Dec 31, 2022 | 1.08B | -37.89M | -3.39% |
| Dec 31, 2021 | 1.12B | 179.84M | 19.18% |
| Dec 31, 2020 | 937.76M | -45.14M | -4.59% |
| Dec 31, 2019 | 982.90M | -57.98M | -5.57% |
| Dec 31, 2018 | 1.04B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Teladoc Health | 2.49B |
| Evolent Health | 2.10B |
| GoodRx Holdings | 785.23M |
| Phreesia | 495.59M |
| Certara | 421.75M |
| HealthStream | 321.12M |
| Weave Communications | 257.79M |
| NRC Health | 140.00M |
CTEV News
- 2 days ago - Claritev Corporation Announces Participation in Upcoming Events - Business Wire
- 9 days ago - Claritev price target raised to $40 from $28 at Barclays - TheFly
- 12 days ago - Marpai expand relationship with Claritev - TheFly
- 12 days ago - Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients - Business Wire
- 18 days ago - Claritev price target raised to $30 from $22 at Wells Fargo - TheFly
- 18 days ago - Claritev Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 19 days ago - Claritev price target raised to $43 from $37 at Canaccord - TheFly
- 19 days ago - Claritev price target raised to $45 from $40 at Citi - TheFly